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Case Report
Myotonic Dystrophy Type 1 Presenting as Male Infertility 
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Myotonic dystrophy 1 (DM1) is a multi-system disorder characterized by endocrine de-
fects that include testicular and tubular atrophy, oligospermia and azoospermia, and 
increased follicle-stimulating hormone levels. We describe a rare case of DM1 present-
ing as infertility in a 29-year-old man.
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Myotonic dystrophy 1 (DM1) is defined as a hereditary, au-
tosomal dominant multi-system disorder characterized by 
the development of structural and functional abnormal-
ities in the muscle membrane protein associated with mus-
cular dystrophy, cardiac conduction disorders, cataracts, 
mental retardation, and endocrine and reproductive de-
fects [1]. The genetic mutation in DM1 is the expansion of 
a CTG repeat sequence found in the 3’-untranslated region 
of the myotonic dystrophy protein kinase (DMPK) gene lo-
cated on chromosome 19q13.3 [2,3]. Reproductive abnor-
malities are a well-recognized finding in DM1. Progressive 
testicular atrophy is a prominent feature and occurs with 
an incidence of approximately 80%. Histological abnormal-
ities include hyalinization, atrophy, fibrosis of semini-
ferous tubules, and reduced sperm numbers [1]. Oligosper-
mia and azoospermia are reported in approximately 73% 
of DM1 patients [4]. Herein, we report a case of a patient 
with azoospermia associated with DM1 and review the 
literature. 
CASE REPORT
A 29-year-old man was seen in our clinic over a 2-year dura-
tion for infertility. His medical history did not include cryp-
torchidism, herniorrhaphies, orchitis, mumps, or drug 
ingestion. He appeared healthy, and his height and body 
weight were 171 cm and 70 kg, respectively. However, the 
patient complained of progressive, mild distal extremities 
weakness for the past 3 years. He could not endure a heavy 
burden of more than 10 kg. The physical exam revealed soft, 
atrophied testicle on palpation, measuring 5 ml, bilate-
rally, with preserved epididymis and vas. The size of the 
penis and pubic hair growth were unremarkable. He did 
not complain of any erectile problems. Neurologic exami-
nation demonstrated 4-4+/5 strength at the proximal ex-
tremities and 3-3+/5 strength at the distal extremities. 
Semen analysis performed 2 times after an appropriate ab-
stinence period demonstrated a low ejaculate volume (＜1 
ml) with azoospermia. Post-ejaculate urinalysis also show-
ed no sperm. Endocrine evaluation revealed a plasma leu-
tenizing hormone level of 2.97 mIU/ml (0.4 to 5.7) and tes-
tosterone level of 668.80 ng/ml (241 to 827), but his plasma 
follicle stimulating hormone level was elevated at 30.33 
mIU/ml (1.1 to 13.5). A testicular biopsy was performed giv-
en concerns for primary testicular failure. The biopsy re-
sults revealed hypospermatogenesis (Fig. 1A), atrophy, 
and marked hyalization of the seminiferous tubules (Fig. 
1B). Needle electromyography demonstrated an early in-
terference pattern and myotonic discharge at the distal ex-
tremities, which is a pathognomonic finding for DM1 (Fig. 
2). Gene analysis revealed an expansion of the CTG repeat 
sequence of up to 833 copies, thus confirming classic DM1. Korean J Urol 2012;53:134-136
Myotonic Dystrophy and Infertility 135
FIG. 1. (A) Testicular biopsy revealed hypospermatogenesis (H&E, x100), (B) atrophy, and marked hyalization of the seminiferous 
tubules (H&E, x400).
FIG. 2. Needle electromyography demonstrated myotonic 
discharge at the distal extremities.
The patient was informed that having a baby might be pos-
sible by intracytoplasmic sperm injection (ICSI); however, 
it would result in the heritable disease among his offspring. 
DISCUSSION
DM1 is the most common cause of an inherited, adult-on-
set, muscular dystrophy [5]. Symptoms include muscle 
atrophy, cataracts, male infertility, and endocrinopathies. 
The disease is caused by an expansion of an unstable CTG 
trinucleotide repeat on chromosome 19q13.3 of a gene that 
codes for a serine-threonine kinase. The size of the unstable 
repeat appears to be related to the age at onset and to the 
severity of the disease; the largest repeat sizes are seen in 
persons with congenital DM1 [5]. In the normal population, 
the number of CTG repeats is polymorphic, ranging from 
5 to 37 copies [3]. A minimal amplification of the repeat, 
ranging from 42 to 80 copies, designates mild DM1, which 
is characterized by no or only mild manifestations of the 
disease. In classic DM1, the copy number of CTG repeats 
is usually ＞80, which causes a more severe phenotype [6]. 
Our patient had 833 copies and belonged to this category. 
To our knowledge, this is the first case of male infertility 
associated with DM1 in Korea. Although there are no data 
on the prevalence of DM1 in Korea, the Japanese, an eth-
nicity similar to Koreans, have a comparable or higher 
prevalence of DM1 (5.5/100,000) compared with West 
Europeans (2.5 to 5.5/100,000) [7]. Reproductive abnor-
malities are a well-recognized finding in DM1. Nearly two 
thirds of men have testicular atrophy and many will have 
oligospermia or azoospermia [5]. Although ICSI has be-
come a powerful technology for men with various sperma-
togenic disorders to increase their prospects of parenthood, 
genetic consultation with these infertile patients is of great 
concern. Recent studies have suggested that many of the 
so-called idiopathic azoospermia may have a genetic basis 
[8]. It has been proposed that larger CTG repeat alleles in 
the DMPK gene might be associated with idiopathic azoo-
spermia [9]. This implies that some patients with idio-
pathic azoospermia may be carriers of larger trinucleotide 
repeat alleles, ultimately leading to increased incidences 
of heritable diseases among their offspring [9]. Genetic dis-
eases that do not primarily affect the genitourinary tract 
may have hidden urologic manifestations such as infer-
tility. Thus, the practicing urologist should have knowl-
edge of these diseases.
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